Evolving classification systems for cancer cachexia: Ready for clinical practice?

Supportive Care in Cancer

Volumn 18, Issue 3, 2010, Pages 273-279

  Blum, David ^a   Omlin, Aurelius ^a   Fearon, Ken ^b   Baracos, Vickie ^c   Radbruch, Lukas ^d   Kaasa, Stein ^e   Strasser, Florian ^a  

^a Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ALBERTA   (Canada)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Cancer; Cancer cachexia; Classification systems

Indexed keywords

CANNABINOID; CORTICOSTEROID; GESTAGEN; PROKINETIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADVANCED CANCER; CACHEXIA; CANCER PATIENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DISEASE CLASSIFICATION; HUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; TOTAL PARENTERAL NUTRITION; WEIGHT REDUCTION;

ADRENAL CORTEX HORMONES; CACHEXIA; CANNABINOIDS; COUNSELING; CYCLOOXYGENASE INHIBITORS; EICOSAPENTAENOIC ACID; HUMANS; NEOPLASMS; PARENTERAL NUTRITION, TOTAL; PROGESTINS;

EID: 77949272095     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0800-6     Document Type: Review

References (54)

1. F Bozzetti on behalf of the SCRINIO Working Group 2009 Screening the nutritional status in oncology: a preliminary report on 1, 000 outpatients Support Care Cancer 17 3 279 284 10.1007/s00520-008-0476-3 18581148
2. JB Hopkinson DN Wright JW McDonald JL Corner 2006 The prevalence of concern about weight loss and change in eating habits in people with advanced cancer J Pain Symptom Manage 32 322 331 10.1016/j.jpainsymman.2006.05.012 17000349 (Pubitemid 44430134)
3. MP Davis D Dickerson 2000 Cachexia and anorexia: cancer's covert killer Support Care Cancer 8 180 187 10.1007/s005200050282 1:STN:280: DC%2BD3c3kvVyiuw%3D%3D 10789957
4. CL Loprinzi 1995 Management of cancer anorexia/cachexia Support Care Cancer 3 120 122 10.1007/BF00365851 1:STN:280:DyaK2M3ptFKnsg%3D%3D 7773579
5. https://webapps.ctep.nci.nih.gov/webobjs/ctc/webhelp/welcome-to-ctcae.htm
6. A Jatoi K Rowland CL Loprinzi JA Sloan SR Dakhil N MacDonald B Gagnon PJ Novotny JA Mailliard TI Bushey S Nair B Christensen North Central Cancer Treatment Group 2004 An eicosapentaenoic acid supplement versus megestrol acetateversus both for patients with cancer-associated wasting: a North Central CancerTreatment Group and National Cancer Institute of Canada collaborative effort J Clin Oncol 22 12 2469 2476 10.1200/JCO.2004.06.024 1:CAS:528: DC%2BD2cXpsVWksr4%3D 15197210 (Pubitemid 41115406)
7. A Jatoi HE Windschitl CL Loprinzi JA Sloan SR Dakhil JA Mailliard S Pundaleeka CG Kardinal TR Fitch JE Krook PJ Novotny B Christensen 2002 Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study J Clin Oncol 20 2 567 573 10.1200/JCO.20.2.567 1:CAS:528:DC%2BD38XovVKhtg%3D%3D 11786587 (Pubitemid 34072541)
8. WJ Evans JE Morley J Argilés C Bales V Baracos D Guttridge A Jatoi K Kalantar-Zadeh H Lochs G Mantovani D Marks WE Mitch M Muscaritoli A Najand P Ponikowski F Rossi Fanelli M Schambelan A Schols M Schuster D Thomas R Wolfe SD Anker 2008 Cachexia: a new definition Clin Nutr 27 6 793 799 10.1016/j.clnu.2008.06.013 1:CAS:528:DC%2BD1cXhsVWrsbzI 18718696
9. F Bozzetti L Mariani 2009 Defining and classifying cancer cachexia: a proposal by the SCRINIO working group JPEN J Parenter Enteral Nutr 33 4 361 367 10.1177/0148607108325076 19109514
10. P Stone M Richards R A'Hern J Hardy 2000 A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer Ann Oncol 11 5 561 567 10.1023/A:1008331230608 1:STN:280:DC%2BD3M%2Fms1Ogsw%3D%3D 10907949 (Pubitemid 30431378)
11. F Strasser 2008 Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue Curr Opin Clin Nutr Metab Care 11 4 417 421 10.1097/MCO.0b013e3283025e27 18542001
12. G Birgegård MS Aapro C Bokemeyer M Dicato P Drings J Hornedo M Krzakowski H Ludwig S Pecorelli H Schmoll M Schneider D Schrijvers D Shasha S Van Belle 2005 Cancer-related anemia: pathogenesis, prevalence and treatment Oncology 68 Suppl 1 3 11 10.1159/000083128 15855811 (Pubitemid 40663255)
13. A Knudsen N Aass R Fainsinger A Caraceni P Klepstad M Jordhøy M Hjermstad S Kaasa 2009 Classification of pain in cancer patients-a systematic literature review Palliat Med 23 295 308 10.1177/0269216309103125 1:STN:280:DC%2BD1MzjsFKnug%3D%3D 19286741
14. L Rayner JH Loge E Wasteson IJ Higginson 2009 EPCRC, European Palliative Care Research Collaborative. The detection of depression in palliative care Curr Opin Support Palliat Care 3 55 60 10.1097/SPC.0b013e328326b59b 19365162
15. D Koeberle P Saletti M Borner D Gerber D Dietrich, et al. 2008 Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research J Clin Oncol 26 3702 3708 10.1200/JCO.2008.16.5704 1:CAS:528:DC%2BD1cXhtVGjs73P 18669455
16. Y Takahashi K Yasumoto M Mai 2005 Chemotherapy under cachectic conditions and the possibility of cachexia-controlled chemotherapy Oncol Rep 14 135 140 1:CAS:528:DC%2BD2MXmt1Churw%3D 15944780
17. P Ravasco I Monteiro Grillo M Camilo 2007 Cancer wasting and quality of life react to early individualized nutritional counselling! Clin Nutr 26 7 15 10.1016/j.clnu.2006.10.005 17166637 (Pubitemid 46179128)
18. http://www.epcrc.org/publication-listfiles.php?id=CeuErsu91kDCfzJeCY3y
19. VE Baracos 2006 Cancer-associated cachexia and underlying biological mechanisms Annu Rev Nutr 26 13.1 13.27 10.1146/annurev.nutr.26.061505.111151
20. MJ Tisdale 2008 Catabolic mediators of cancer cachexia Curr Opin Support Palliat Care 2 4 256 261 10.1097/SPC.0b013e328319d7fa 19069310
21. T Yavuzsen PD Mellar D Walsh, et al. 2005 Systematic review of the treatment of cancer-associated anorexia and weight loss J Clin Oncol 85 8500 8511 10.1200/JCO.2005.01.8010 (Pubitemid 46260247)
22. KC Fearon MD Barber AG Moses, et al. 2006 Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia J Clin Oncol 24 3401 3407 10.1200/JCO.2005.04.5724 1:CAS:528:DC%2BD28Xot1KisL8%3D 16849754 (Pubitemid 46638896)
23. F Strasser D Luftner K Possinger, et al. 2006 Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-relatedanorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group J Clin Oncol 24 3394 3400 10.1200/JCO.2005.05. 1847 1:CAS:528:DC%2BD28Xot1KisL4%3D 16849753 (Pubitemid 46638895)
24. N Sarhill F Mahmoud D Walsh KA Nelson S Komurcu M Davis S LeGrand O Abdullah L Rybicki 2003 Evaluation of nutritional status in advanced metastatic cancer Support Care Cancer 11 10 652 659 10.1007/s00520-003-0486-0 1:STN:280:DC%2BD3svltFensg%3D%3D 12920623 (Pubitemid 37243596)
25. VT Chang Q Xia B Kasimis 2005 The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) appetite scale in veteran cancer patients J Support Oncol 3 377 382 16218262
26. M Fouladiun U Korner I Bosaeus P Daneryd A Hyltander KG Lundholm 2005 Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones Cancer 103 10 2189 2198 10.1002/cncr.21013 15822132 (Pubitemid 40605128)
27. KC Fearon AC Voss DS Hustead 2006 Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Am J Clin Nutr 83 6 1345 1350 1:CAS:528:DC%2BD28XlvFCmtbg%3D 16762946
28. I Bosaeus P Daneryd E Svanberg K Lundholm 2001 Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients Int J Cancer 93 3 380 383 10.1002/ijc.1332 1:CAS:528:DC%2BD3MXlt12gsbw%3D 11433403 (Pubitemid 32592057)
29. D Walsh S Donnelly L Rybicki 2000 The symptoms of advanced cancer: relationship to age, gender, and performance status in 1, 000 patients Support Care Cancer 8 3 175 179 10.1007/s005200050281 1:STN:280:DC%2BD3c3kvVyiug%3D%3D 10789956
30. SC Teunissen W Wesker C Kruitwagen HC de Haes EE Voest A de Graeff 2007 Symptom prevalence in patients with incurable cancer: a systematic review J Pain Symptom Manage 34 1 94 104 10.1016/j.jpainsymman.2006.10.015 17509812 (Pubitemid 46970881)
31. C Tishelman LM Petersson LF Degner MA Sprangers 2007 Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death J Clin Oncol 25 34 5381 5389 10.1200/JCO.2006.08.7874 18048819 (Pubitemid 350232213)
32. PW Pisters E Cersosimo A Rogatko MF Brennan 1992 Insulin action on glucose and branched-chain amino acid metabolism in cancer cachexia: differential effects of insulin Surgery 111 3 301 310 1:STN:280: DyaK387nvFyrtg%3D%3D 1542855
33. E Del Fabbro S Dalal M Delgado G Freer E Bruera 2007 Secondary vs primary cachexia in patients with advanced cancer J Clin Oncol 25 9128
34. JL Hutton VE Baracos WV Wismer 2007 Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer J Pain Symptom Manage 33 156 165 10.1016/j.jpainsymman.2006.07.017 17280921 (Pubitemid 46186864)
35. BM Bernhardson C Tishelman LE Rutqvist 2008 Self-reported taste and smell changes during cancer chemotherapy Support Care Cancer 16 3 275 283 10.1007/s00520-007-0319-7 17710445
36. EB Rubenstein DE Peterson M Schubert, et al. 2004 Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis Cancer 100 9 Suppl 2026 2046 10.1002/cncr.20163 15108223
37. ST Sonis EG Fey 2002 Oral complications of cancer therapy Oncology (Williston Park) 16 680 686
38. E Bruera JR Moyano R Sala MA Rico S Bosnjak M Bertolino J Willey F Strasser JL Palmer 2004 Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial J Pain Symptom Manage 28 4 381 388 10.1016/j.jpainsymman.2004.01.009 1:CAS:528:DC%2BD2cXhtVaisbnJ 15471656 (Pubitemid 39313167)
39. Strasser F (2003) Management of specific symptoms and syndromes: constipation. In: Bruera E, Fisch M (eds) Cambridge Handbook of Advanced Cancer Care Chapter 49. Cambridge University Press, Cambridge, pp 397-497
40. L Qian WC Orr JD Chen 2002 Inhibitory reflexive effect of rectal distension on postprandial gastric myoelectrical activity Dig Dis Sci 47 11 2473 2479 10.1023/A:1020551824234 12452382 (Pubitemid 35305455)
41. S Mercadante P Villari P Ferrera A Casuccio 2006 Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Eur J Pain 10 2 153 159 10.1016/j.ejpain.2005.02.006 1:CAS:528:DC%2BD2MXht1GhurrI 16310719 (Pubitemid 41727765)
42. TY Chiu WY Hu BH Lue CA Yao CY Chen S Wakai 2004 Dyspnea and its correlates in taiwanese patients with terminal cancer J Pain Symptom Manage 28 2 123 132 10.1016/j.jpainsymman.2003.11.009 15276193 (Pubitemid 38970075)
43. M Grosvenor L Bulcavage RT Chlebowski 1989 Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy dministration Cancer 63 2 330 334 10.1002/1097-0142(19890115)63:2<330::AID-CNCR2820630221>3.0.CO;2-U 1:STN:280:DyaL1M%2FovFGgtA%3D%3D 2910438 (Pubitemid 19035027)
44. Strasser F, Bruera E (eds) (2002) Cancer anorexia/cachexia syndrome: epidemiology, pathogenesis, and assessment. In gastrointestinal symptoms in advanced cancer patients. Oxford University Press, Oxford
45. F Strasser J Binswanger T Cerny, et al. 2007 Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study Palliat Med 21 129 137 10.1177/0269216307076346 1:STN:280:DC%2BD2s7ksVagsw%3D%3D 17344261 (Pubitemid 46455839)
46. JE Shragge WV Wismer KL Olson VE Baracos 2007 Shifting to conscious control: psychosocial and dietary management of anorexia by patients with advanced cancer Palliat Med 21 227 233 10.1177/0269216307077172 17641076 (Pubitemid 46958249)
47. KF Giordano A Jatoi 2005 The cancer anorexia/weight loss syndrome: therapeutic challenges Curr Oncol Rep 7 271 276 10.1007/s11912-005-0050-9 15946586
48. D Hoda A Jatoi J Burnes C Loprinzi D Kelly 2005 Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience Cancer 103 4 863 868 10.1002/cncr.20824 15641035 (Pubitemid 40216417)
49. E Bruera M Belzile C Neumann, et al. 2000 A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer J Pain Symptom Manage 19 6 427 435 10.1016/S0885-3924(00)00138-X 1:STN:280:DC%2BD3cvivFWgtQ%3D%3D 10908823 (Pubitemid 30447368)
50. EG Berenstein Z Ortiz 2005 Megestrol acetate for the treatment ofanorexia-cachexia syndrome Cochrane Database Syst Rev 2 CD004310 15846706
51. JA Read PJ Beale DH Volker N Smith A Childs SJ Clarke 2007 Nutrition intervention using an eicosapentaenoic acid-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial Support Care Cancer 15 301 307 10.1007/s00520-006-0153-3 17021855 (Pubitemid 46295216)
52. KC Fearon MD Barber AG Moses SH Ahmedzai GS Taylor MJ Tisdale, et al. 2006 Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia J Clin Oncol 24 3401 3407 10.1200/JCO.2005.04.5724 1:CAS:528:DC%2BD28Xot1KisL8%3D 16849754 (Pubitemid 46638896)
53. A Dewey C Baughan T Dean B Higgins I Johnson 2007 Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia Cochrane Database Syst Rev 1 CD004597 17253515
54. A Inoue Y Yamada Y Matsumura, et al. 2003 Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan Support Care Cancer 11 528 532 10.1007/s00520-003-0488-y 12844250 (Pubitemid 36994436)